Candawan, Cheana May L.
HRN: 28-85-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2026
CEFUROXIME 750MG (VIAL)
04/14/2026
04/21/2026
IV
750mg
Q8H
Uti
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: